tizanidine

Generic: tizanidine

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine
Generic Name tizanidine
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 4 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-0840
Product ID 50090-0840_5bcdf097-1022-4183-8571-402c2dc943f2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076286
Listing Expiration 2026-12-31
Marketing Start 2002-07-03

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500900840
Hyphenated Format 50090-0840

Supplemental Identifiers

RxCUI
313412 313413
UNII
B53E3NMY5C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine (source: ndc)
Generic Name tizanidine (source: ndc)
Application Number ANDA076286 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (50090-0840-0)
  • 60 TABLET in 1 BOTTLE (50090-0840-2)
  • 15 TABLET in 1 BOTTLE (50090-0840-3)
  • 30 TABLET in 1 BOTTLE (50090-0840-4)
  • 90 TABLET in 1 BOTTLE (50090-0840-6)
  • 14 TABLET in 1 BOTTLE (50090-0840-7)
source: ndc

Packages (6)

Ingredients (1)

tizanidine hydrochloride (4 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5bcdf097-1022-4183-8571-402c2dc943f2", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["180985f0-3fbd-4868-a826-b84101618a03"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (50090-0840-0)", "package_ndc": "50090-0840-0", "marketing_start_date": "20141128"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-0840-2)", "package_ndc": "50090-0840-2", "marketing_start_date": "20141128"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (50090-0840-3)", "package_ndc": "50090-0840-3", "marketing_start_date": "20141128"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-0840-4)", "package_ndc": "50090-0840-4", "marketing_start_date": "20141128"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-0840-6)", "package_ndc": "50090-0840-6", "marketing_start_date": "20141128"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (50090-0840-7)", "package_ndc": "50090-0840-7", "marketing_start_date": "20141128"}], "brand_name": "Tizanidine", "product_id": "50090-0840_5bcdf097-1022-4183-8571-402c2dc943f2", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "50090-0840", "generic_name": "Tizanidine", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20020703", "listing_expiration_date": "20261231"}